GENE ONLINE|News &
The Investment Calculus: What the Neurodegenerative Market Looks Like Right Now
Approvals have unlocked commercial momentum, M&A valuations are rising, and a wave of second-generation therapies is approaching. Knowing which signals to follow — and which to discount — is the work of the moment. Image: Shutterstock
The neurodegenerative disease market is at an inflection point that investors have been anticipating for years. With two FDA-approved anti-amyloid therapies now in commercial markets, …
The Investment Calculus: What the Neurodegenerative Market Looks Like Right Now Read More »
It's free! Log in now to read
LATEST
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
